Loading clinical trials...
Loading clinical trials...
The Effect of Peptide Immunotherapy on Frequency, Memory Phenotype, Chemokine Receptor Expression and Markers of Regulatory T Cell Function Among Allergen-Specific T Cells
Conditions
Interventions
Cat-PAD
Placebo
Locations
1
Canada
St. Joseph's Healthcare
Hamilton, Ontario, Canada
Start Date
March 9, 2015
Primary Completion Date
July 18, 2018
Completion Date
July 18, 2018
Last Updated
November 2, 2018
NCT04981717
NCT02399579
NCT01272323
NCT01033344
NCT00729508
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions